News
As we continue to see sequencing technologies advance and provide a deeper understanding of gene therapy targets along with ...
A Minnesota woman was told her stage 4 colon cancer couldn’t be cured. Two years later, she’s cancer-free — and says a ...
1d
New Scientist on MSNBaby with rare disease given world-first personal CRISPR gene therapyAn infant with a severe genetic condition has shown signs of improvement after receiving a gene-editing treatment tailored to ...
Ask scientists which gene-editing tool is most needed to advance gene therapy, and they'd probably describe a system that's ...
The UNC technology, developed by Pediatrics Professor Chengwen Li, M.D., Ph.D., uses adeno-associated viruses (AAVs) to ferry ...
Researchers have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results show ...
May 15, 2025 — A research team has developed and safely delivered a personalized gene editing therapy to treat an infant with a life-threatening, incurable genetic disease. The infant, who was ...
15h
News Medical on MSNNew gene editor evoCAST enables precise insertion of complete genesAsk scientists what gene editing tool is most needed to advance gene therapy, and they'd probably describe a system that's now close to realization in the labs of Samuel Sternberg at Columbia ...
To address this challenge, CTMC has established a patient material bank, enabling early-stage process development with clinically relevant samples. This resource also supports continuous process ...
Instead of killing all fast-growing cells or keeping them from dividing, targeted therapies work more selectively against cancer cells. They do one of three things: They target a gene or protein that ...
3d
Verywell Health on MSNWhat Happens When Hormone Treatment for Prostate Cancer Stops Working?Once prostate cancer no longer responds to hormonal therapy, the cancer is called castration-resistant. Find out which ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results